HERON THERAPEUTICS INC shareholders Q3 2023

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
Congress Park Capital LLC 589,150$606,8250.32%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,905,5000.27%
Monaco Asset Management SAM 696,908$717,8150.21%
Richmond Brothers, Inc. 103,009$106,1000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,110,951$4,234,2800.12%
Deep Track Capital, LP 2,086,704$2,149,3050.08%
NEXPOINT ASSET MANAGEMENT, L.P. 499,131$514,1050.07%
Simplify Asset Management Inc. 431,590$444,5380.05%
Baker Brothers Advisors 8,131,678$8,375,6280.05%
Zweig-DiMenna Associates LLC 320,130$329,7340.04%
External links

This page lists HERON THERAPEUTICS INC's shareholders in Q3 2023. To view HERON THERAPEUTICS INC's shareholder history, click here.